Allison Kempe1, Sean T O'Leary2, Jo Ann Shoup3, Shannon Stokley4, Steven Lockhart5, Anna Furniss5, L Miriam Dickinson6, Juliana Barnard5, Matthew F Daley7. 1. Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado; Departments of Pediatrics, and allison.kempe@childrenscolorado.org. 2. Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado; Departments of Pediatrics, and. 3. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado; and. 4. National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 5. Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado; 6. Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado; Family Medicine, University of Colorado, Aurora, Colorado; 7. Departments of Pediatrics, and Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado; and.
Abstract
OBJECTIVES:Completion rates for the human papillomavirus vaccine (HPV) series among adolescents remain low. Effectiveness of recall with parents choosing the method (preference-based recall) for increasing HPV series completion is unstudied. Within a cluster-randomized trial, we examined effectiveness of preference-based recall compared with usual care for increasing series completion and the association of recall choices with completion. METHODS:All Kaiser Permanente Colorado pediatric practices (n = 7) were randomized to intervention (n = 4) or control (n = 3) by using covariate-constrained randomization. From January to June 2013, parents at intervention practices whose adolescents received HPV 1 were asked the recall method they preferred for subsequent doses and if they also wanted their child reminded. Completion rates were assessed 1 year after HPV 1. RESULTS: At intervention practices, 374 (43%) of 867 patients were enrolled; 39% preferred text, 18% e-mail, 9% auto-dialer, and 34% 2-methods; 19% chose to have adolescent also recalled. Intervention adolescents were more likely to complete (63% vs 38%) than were controls (adjusted risk ratio 1.47 [1.38-1.57]) and less likely to be late in completing the series (45% vs 57%, P = .02). Rates of completion were similar between different recall methods, but significantly higher for those preferring e-mail and phone compared withother methods (90% vs 60%. P = .008). Completion rates were similar for adolescents who also received recalls (62%) versus those who did not (63%). CONCLUSIONS: Preference-based recall was effective in increasing HPV series completion rates, with point estimates substantially higher than for most published studies of reminder/recall.
RCT Entities:
OBJECTIVES: Completion rates for the human papillomavirus vaccine (HPV) series among adolescents remain low. Effectiveness of recall with parents choosing the method (preference-based recall) for increasing HPV series completion is unstudied. Within a cluster-randomized trial, we examined effectiveness of preference-based recall compared with usual care for increasing series completion and the association of recall choices with completion. METHODS: All Kaiser Permanente Colorado pediatric practices (n = 7) were randomized to intervention (n = 4) or control (n = 3) by using covariate-constrained randomization. From January to June 2013, parents at intervention practices whose adolescents received HPV 1 were asked the recall method they preferred for subsequent doses and if they also wanted their child reminded. Completion rates were assessed 1 year after HPV 1. RESULTS: At intervention practices, 374 (43%) of 867 patients were enrolled; 39% preferred text, 18% e-mail, 9% auto-dialer, and 34% 2-methods; 19% chose to have adolescent also recalled. Intervention adolescents were more likely to complete (63% vs 38%) than were controls (adjusted risk ratio 1.47 [1.38-1.57]) and less likely to be late in completing the series (45% vs 57%, P = .02). Rates of completion were similar between different recall methods, but significantly higher for those preferring e-mail and phone compared withother methods (90% vs 60%. P = .008). Completion rates were similar for adolescents who also received recalls (62%) versus those who did not (63%). CONCLUSIONS: Preference-based recall was effective in increasing HPV series completion rates, with point estimates substantially higher than for most published studies of reminder/recall.
Authors: Kirsten S Vannice; Daniel A Salmon; Irene Shui; Saad B Omer; Jennifer Kissner; Kathryn M Edwards; Robert Sparks; Cornelia L Dekker; Nicola P Klein; Deborah A Gust Journal: Pediatrics Date: 2011-04-18 Impact factor: 7.124
Authors: Matthew F Daley; Jennifer Barrow; Kellyn Pearson; Lori A Crane; Dexiang Gao; John M Stevenson; Stephen Berman; Allison Kempe Journal: Pediatrics Date: 2004-01 Impact factor: 7.124
Authors: Nancy Krieger; Jarvis T Chen; Pamela D Waterman; David H Rehkopf; S V Subramanian Journal: Am J Public Health Date: 2003-10 Impact factor: 9.308
Authors: Jennifer L Kraschnewski; Thomas C Keyserling; Shrikant I Bangdiwala; Ziya Gizlice; Beverly A Garcia; Larry F Johnston; Alison Gustafson; Lindsay Petrovic; Russell E Glasgow; Carmen D Samuel-Hodge Journal: Prev Chronic Dis Date: 2009-12-15 Impact factor: 2.830
Authors: Nicole M Wagner; Amanda F Dempsey; Komal J Narwaney; Kathy S Gleason; Courtney R Kraus; Jennifer Pyrzanowski; Jason M Glanz Journal: Vaccine Date: 2021-05-28 Impact factor: 4.169
Authors: Julie C Jacobson Vann; Robert M Jacobson; Tamera Coyne-Beasley; Josephine K Asafu-Adjei; Peter G Szilagyi Journal: Cochrane Database Syst Rev Date: 2018-01-18
Authors: Anna Acampora; Adriano Grossi; Andrea Barbara; Vittoria Colamesta; Francesco Andrea Causio; Giovanna Elisa Calabrò; Stefania Boccia; Chiara de Waure Journal: Int J Environ Res Public Health Date: 2020-10-30 Impact factor: 3.390